Our findings indicate that circHIPK3 acts as an oncogene in ESCC and that the circHIPK3-AKT3_xis may be a therapeutic target for patients with ESCC.
circHIPK3 regulates cell proliferation and migration by sponging microRNA-124 and regulating serine/threonine kinase 3 expression in esophageal squamous cell carcinoma.